These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18309785)

  • 1. Using Drosophila models to unravel pathogenic mechanisms that underlie neurodegeneration in tauopathies.
    Mudher A; Newman TA; Chee F; Shepherd D
    SEB Exp Biol Ser; 2008; 60():25-38. PubMed ID: 18309785
    [No Abstract]   [Full Text] [Related]  

  • 2. Modelling cell and isoform type specificity of tauopathies in Drosophila.
    Grammenoudi S; Anezaki M; Kosmidis S; Skoulakis EM
    SEB Exp Biol Ser; 2008; 60():39-56. PubMed ID: 18309786
    [No Abstract]   [Full Text] [Related]  

  • 3. Studying tauopathies in Drosophila: A fruitful model.
    Sun M; Chen L
    Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.
    Chanu SI; Sarkar S
    Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic animal models of tauopathies.
    Lee VM; Kenyon TK; Trojanowski JQ
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):251-9. PubMed ID: 15615643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of tauopathies by comparing Drosophila and human tau in Drosophila.
    Chen X; Li Y; Huang J; Cao D; Yang G; Liu W; Lu H; Guo A
    Cell Tissue Res; 2007 Jul; 329(1):169-78. PubMed ID: 17406902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy.
    Sealey MA; Vourkou E; Cowan CM; Bossing T; Quraishe S; Grammenoudi S; Skoulakis EMC; Mudher A
    Neurobiol Dis; 2017 Sep; 105():74-83. PubMed ID: 28502805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The power and richness of modelling tauopathies in Drosophila.
    Papanikolopoulou K; Skoulakis EM
    Mol Neurobiol; 2011 Aug; 44(1):122-33. PubMed ID: 21681411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hSOD1 promotes tau phosphorylation and toxicity in the Drosophila model.
    Huang Y; Wu Z; Zhou B
    J Alzheimers Dis; 2015; 45(1):235-44. PubMed ID: 25524953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau pathophysiology in neurodegeneration: a tangled issue.
    Spires-Jones TL; Stoothoff WH; de Calignon A; Jones PB; Hyman BT
    Trends Neurosci; 2009 Mar; 32(3):150-9. PubMed ID: 19162340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress mediates tau-induced neurodegeneration in Drosophila.
    Dias-Santagata D; Fulga TA; Duttaroy A; Feany MB
    J Clin Invest; 2007 Jan; 117(1):236-45. PubMed ID: 17173140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
    Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
    Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights from Drosophila models of Alzheimer's disease.
    Cowan CM; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):988-92. PubMed ID: 20658990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration.
    Karsten SL; Sang TK; Gehman LT; Chatterjee S; Liu J; Lawless GM; Sengupta S; Berry RW; Pomakian J; Oh HS; Schulz C; Hui KS; Wiedau-Pazos M; Vinters HV; Binder LI; Geschwind DH; Jackson GR
    Neuron; 2006 Sep; 51(5):549-60. PubMed ID: 16950154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bin1 directly remodels actin dynamics through its BAR domain.
    Dräger NM; Nachman E; Winterhoff M; Brühmann S; Shah P; Katsinelos T; Boulant S; Teleman AA; Faix J; Jahn TR
    EMBO Rep; 2017 Nov; 18(11):2051-2066. PubMed ID: 28893863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation differentiates tau-dependent neuronal toxicity and dysfunction.
    Papanikolopoulou K; Kosmidis S; Grammenoudi S; Skoulakis EM
    Biochem Soc Trans; 2010 Aug; 38(4):981-7. PubMed ID: 20658989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in
    Mao CX; Wen X; Jin S; Zhang YQ
    Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
    Blard O; Feuillette S; Bou J; Chaumette B; Frébourg T; Campion D; Lecourtois M
    Hum Mol Genet; 2007 Mar; 16(5):555-66. PubMed ID: 17309878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.